Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: Concurrent bacterial eradication and acquisition of resistance

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 6, 2005, Pages 1172-1175

  Liu, Youning ^a   Cui, Junchang ^a   Wang, Rui ^a   Wang, Xinjing ^a   Drlica, Karl ^b   Zhao, Xilin ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Antimicrobial resistance; Mutant selection window; S. aureus; TB

Indexed keywords

AMINOSALICYLIC ACID; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; PROTEIN A; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; NONHUMAN; NOSE; NUCLEOTIDE REPEAT; PREDICTION; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RIFAMPIN; SELECTION (GENETICS); STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS;

EID: 29444455519     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki364     Document Type: Article

References (15)

1. Stratton C. Dead bugs don't mutate: Susceptibility issues in the emergence of bacterial resistance. Emerg Infect Dis 2003; 9: 10-6.
2. Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies. Clin Infect Dis 2001; 33 Suppl 3: S147-56.
3. Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: Measurement and potential uses of the mutant selection window. J Infect Dis 2002; 185: 561-5.
4. Sande M, Mandell G. Effect of rifampicin on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1975; 7: 294-7.
5. Shopsin B, Gomez M, Montgomery S et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37: 3556-63.
6. Ichiyama S, Ohta M, Shimokata K et al. Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1991; 29: 2690-5.
7. Liu H, Hou F, Zhang Y et al. Nasal carriage of Staphylococcus aureus in patients on hemodialysis: Relationship with incidence of bacteremia. Med J China PLA 2002; 27: 1041-3.
8. Chen N, Chen Q. Nasal colonization frequency and drug susceptibility of Staphylococcus aureusin college students. Chin J School Doctor 2000; 14: 167-8.
9. Binda G, Domenichini A, Gottardi A et al. Rifampicin, a general review. Arzneimittelforschung 1971; 21: 1908-77.
10. 90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis 1990; 162: 1124-7.
11. Acocella G, Nonis A, Gialdroni-Grassi G et al. Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. Am Rev Respir Dis 1988; 138; 882-5.
12. O'Neil A, Cove J, Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 647-50.
13. Kunin CM, Brandt D, Wood H. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. J Infect Dis 1969; 119: 132-7.
14. Li X, Zhao X, Drlica K. Selection of Streptocoocus pneumoniae mutants having reduced susceptibility to levofloxacin and moxifloxacin. Antimicrob Agents Chemother 2002; 46: 522-4.
15. Fuller JD, Low DE. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 2005; 41: 118-21.